Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

8.24
-0.6200-7.00%
Post-market: 8.20-0.0400-0.49%19:30 EDT
Volume:646.76K
Turnover:5.44M
Market Cap:159.37M
PE:-1.35
High:8.79
Open:8.75
Low:8.21
Close:8.86
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:0.99
T/O Rate:3.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.56
PE(LYR):-1.40

Loading ...

Corbus Pharma names Nishant Saxena chief business officer

Reuters
·
May 21

Corbus Pharmaceuticals Holdings Inc - to Initiate Registrational Study for Crb-701 in Second-Line Hnscc This Summer

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 Asco Crb-701 Data Conference Call

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

GlobeNewswire
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
May 20

Corbus Pharmaceuticals Holdings Inc. Stock Falls 9.8%, Underperforms Peers

Dow Jones
·
May 19

Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 16

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 15

Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates

TIPRANKS
·
May 14

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

THOMSON REUTERS
·
May 14

Corbus Pharmaceuticals Price Target Maintained With a $45.00/Share by Guggenheim

Dow Jones
·
May 13

Oppenheimer Adjusts Price Target on Corbus Pharmaceuticals to $54 From $57, Maintains Outperform Rating

MT Newswires Live
·
May 13

Wedbush Remains a Buy on Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 13

Corbus Pharma CEO presents at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 13

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 13

Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies

TIPRANKS
·
May 13

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 13

Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)

TIPRANKS
·
May 13

Corbus Pharmaceuticals Q1 EPS $(1.23) Misses $(1.22) Estimate

Benzinga Earnings
·
May 12